메뉴 건너뛰기




Volumn 23, Issue 6, 2001, Pages 345-349

Determinants of multiple psychotropic drug use in patients with mild intellectual disabilities or borderline intellectual functioning and psychiatric or behavioral disorders

Author keywords

Hospitals; Intellectual Disability; Mental disorders; Polypharmacy; Psychiatric; Psychotropic drugs

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; LEVOMEPROMAZINE; LITHIUM; NEUROLEPTIC AGENT; OXAZEPAM; PIPAMPERONE; PSYCHOTROPIC AGENT; TRANQUILIZER;

EID: 0035189144     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-8343(01)00164-5     Document Type: Article
Times cited : (30)

References (22)
  • 3
    • 0006752204 scopus 로고    scopus 로고
    • Reiss S. Introduction. In: Handbook of challenging behavior: mental health aspects of mental retardation. Worthington, Ohio, IDS Publishing Corporation, 1994. p. 1-40.
  • 4
    • 0002718306 scopus 로고    scopus 로고
    • Psychopathology in mental retardation
    • Jacobson J.W., Mulick J.A. (Eds.), Manual of diagnosis and professional practice in mental retardation, Washington DC: American Psychological Association
    • (1996) , pp. 147-156
    • Rojahn, J.1    Tassé, M.J.2
  • 5
    • 0001789939 scopus 로고
    • Mental retardation, and mental health. Concepts, aetiology, and incidence
    • Bouras N. (Ed.), Mental health in mental retardation. Recent advances and practices, Cambridge, England: Cambridge University Press
    • (1994) , pp. 19-33
    • Szymanski, L.S.1
  • 7
    • 0006730624 scopus 로고    scopus 로고
    • Drug interactions with psychotropic medications
    • Aman M.G., Reiss S. (Eds.), Psychotropic medications and developmental disabilities. The International consensus handbook, Columbus, OH: Ohio State University
    • (1998) , pp. 115-132
    • Sommi, R.W.1    Benefield, W.H.2    Curtis, J.L.3
  • 10
    • 0006161699 scopus 로고    scopus 로고
    • Side effects; recognition, and management
    • Aman M.G., Reiss S. (Eds.), Psychotropic medications and developmental disabilities. The International consensus handbook, Columbus, OH: Ohio State University
    • (1998) , pp. 95-114
    • Gardner Wilson, J.1    Lott, R.S.2    Tsai, L.3
  • 12
    • 0006655578 scopus 로고    scopus 로고
    • Anonymous. ATC classification index with DDDs: January 2001. Oslo, WHO collaborating Centre for Drug Statistics, and Methodology, 2001.
  • 16
    • 0002211619 scopus 로고    scopus 로고
    • Epidemiology, and psychoactive medication
    • Aman M.G., Reiss S. (Eds.), Psychotropic medications and developmental disabilities. The International consensus handbook, Columbus, OH: Ohio State University
    • (1998) , pp. 31-44
    • Rinck, C.1
  • 20
    • 0001805946 scopus 로고    scopus 로고
    • Treatment of extrapyramidal side effects
    • nd edition, Washington, DC, London: American Psychiatric Press, Inc
    • (1998) , pp. 349-375
    • Stanilla, J.K.1    Simpson, G.M.2
  • 21
    • 0001675583 scopus 로고    scopus 로고
    • Mood stabilizers
    • Aman M.G., Reiss S. (Eds.), Psychotropic medications and developmental disabilities. The International consensus handbook, Columbus, OH: Ohio State University
    • (1998) , pp. 215-227
    • Pointdexter, A.R.1    Cain, N.2    Clarke, D.J.3
  • 22
    • 0023853566 scopus 로고
    • Problem behavior, and psychiatric impairment within a developmentally disabled population III; psychotropic medication
    • (1988) Res Dev Disabil , vol.9 , pp. 23-38
    • Jacobson, J.W.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.